麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 15 2026

Full Issue

Viewpoints: Insights From Inventor Of Hepatitis B Vaccine; Need For Medical AI Safety Research Is Urgent

Editorial writers discuss these public health issues.

Baruch Samuel Blumberg, M.D., Ph.D, led the team of American scientists who discovered the hepatitis B virus in 1965, then developed the first screening test and the first vaccine to protect against infection. In 1976, he was awarded the Nobel Prize in Physiology or Medicine for the discovery while working at Fox Chase Cancer Center in Philadelphia. (Emilie G.C. Thompson, 1/15)

On Jan. 6, the Food and Drug Administration released updated guidance for clinical decision support (CDS) tools, relaxing key medical device requirements. With this change, many generative artificial intelligence tools that provide diagnostic suggestions or perform supportive tasks like medical history-taking 鈥 tools that probably would have required FDA sign-off under the prior policy 鈥 could reach clinics without FDA vetting. (Katherine E. Goodman and Daniel Morgan, 1/15)

According to a recent analysis by Nature, FDA approvals appear to be plateauing. The agency鈥檚 Center for Drug Evaluation and Research approved 46 new therapeutic agents in 2025, in line with its five-year average. (Ross Marchand, 1/14)

Health Secretary Robert F. Kennedy Jr. wants to flood the vaccine injury compensation program to hurt vaccine access in the U.S. (Ezekiel J. Emanuel and Paul Friedrichs, 1/15)

The American Academy of Pediatrics, with succinct accuracy, criticized the new recommendations as 鈥渄angerous and unnecessary.鈥 (Christopher Sanford and Paul Pottinger, 1/14)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
  • Tuesday, April 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优